Foradil

 

Topic mentions per year

Topic mentions per year

1998-2017
02419982017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Nebulized solutions of long-acting bronchodilators provide an alternative to DPI and MDI delivery, particularly for COPD patients… (More)
Is this relevant?
2006
2006
Formoterol, a long-acting beta (2)-agonist with a rapid onset of bronchodilation, is available in various delivery devices… (More)
Is this relevant?
2004
2004
In order to characterize the efficacy of dry powder inhalers, in vitro measurements are much easier to perform than human… (More)
Is this relevant?
2004
2004
BACKGROUND For maximum treatment compliance there is a need to provide asthma patients with devices that suit their particular… (More)
Is this relevant?
Review
2004
Review
2004
  • Drugs in R&D
  • 2004
In November 1998, Novartis Pharma of Switzerland and SkyePharma PLC of the UK signed an agreement to jointly develop a new… (More)
Is this relevant?
2003
2003
Standard therapy of asthma consists of combined, antiinflammatory (steroids) and anti-obstructive (long acting/short acting beta… (More)
Is this relevant?
2002
2002
OBJECTIVE At the time of marketing, experience of long-term use of prescription medicines in general clinical practice is limited… (More)
Is this relevant?
2001
2001
Formoterol fumarate is a beta2-agonist bronchodilator that combines a fast onset of action with a long duration of action. Its… (More)
Is this relevant?
1999
1999
Objective: The pharmacokinetics of the long-acting β2-agonist formoterol fumarate, which is a racemate of the (S,S)- and (R,R… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1999
1999
The present study was designed to observe the effects of 8 wk of treatment with formoterol (Foradil) 24 microgram, budesonide 400… (More)
Is this relevant?